VentureFlow

Everything your deal team needs, in one place

Five pillars built for early-stage VC:

PipelineAnalysisPortfolioMeetingsResearch

Pipeline

Two-track pipeline system: Active deals move through Contacted → First Meeting → Due Diligence → Final Stages → Term Sheet. Prospective deals organized in Tier 1/2/3. Every deal card shows composite scores, stage badges, and real-time analysis triggers.

  • Active + Prospective tabs — move deals between tracks instantly
  • Score composite — team/market/product bars with weighted average
  • Search & filter — by scope (mine/shared), sort by score/company/date
  • Section-level permissions — control view/edit/comment per section per user
ActiveProspective
QuantumEdge AI
Deep Tech · Due Diligence
91
Team
Market
Product
BioSynth Corp
Healthcare · First Meeting

AI Deal Analysis

Upload a pitch deck. Textract extracts text, Claude Haiku fills in deal fields automatically. Then Claude Opus runs deep analysis: trends, SWOT, risks, comparable exits, founder-market fit score, and portfolio synergies.

TRENDS
  • • Autonomous robotics market growing at 28% CAGR
  • • Recent $2B acquisition validates competitive landscape
  • • Manufacturing labor shortage accelerating adoption
  • • Gov't incentives for domestic production
COMPETITIVE LANDSCAPE
Direct competitors:4 funded startups
Market leaders:2 incumbents
Differentiation:Strong
SWOT ANALYSIS
Strengths: Strong IP, experienced team
Weaknesses: Limited GTM experience
Opportunities: Gov't contracts, Asia expansion
Threats: Well-funded competitors
COMPARABLE EXITS
RoboTech Inc.$450M (2024)
AutoSys Corp.$680M (2023)
ManufactAI$320M (2023)
FOUNDER-MARKET FIT SCORE
88

Founder has 10+ years in robotics, PhD from MIT, prior successful exit in adjacent space

Deal Q&A Chat

Conversational interface with Claude Sonnet. Full deal context, persistent chat history, and the ability to ask anything about the company, market, or team.

You
What are the biggest risks with this deal?
AI

Based on the pitch deck and market analysis, here are the three main risks:

  1. 1. Go-to-market execution — team lacks enterprise sales experience
  2. 2. Competitive pressure — two well-funded competitors ahead in market
  3. 3. Regulatory timeline — manufacturing certifications could delay rollout
You
How does this compare to our Biotech portfolio companies?

Portfolio

Track completed investments with outcome data, valuation tracking, and notes. View past investments per team member. Firm portfolio tab shows the entire team's investment history.

CloudScale Inc.
Series A · 2024
Invested:$2M
Valuation:$45M
DataFlow AI
Seed · 2023
Invested:$500K
Valuation:$18M
HealthTech Pro
Series A · 2023
Invested:$1.5M
Outcome:Acquired

Meetings

Schedule meetings with invitees and linked deals. Presentation mode gives you live deal access with note-taking, pitch deck preview, and tag decisions. AI generates structured summaries after.

Partner Meeting — QuantumEdge AI
Today 2:00 PM · 3 deals linked
Live Notes
Strong technical depth, team has built robotics systems before. Market timing looks good with labor shortage...
Tag Decision

Projects

Workspaces for research, incubation, or deal evaluation. Each project has Chats (AI threads), Context (reference files), and Assets (generated deliverables). Share with view/edit access.

Chats
AI conversation threads with persistent history
Context
Upload reference files for AI to use
Assets
Generated deliverables and outputs

Research & News

AI-generated headlines across 8 categories. Persistent chat with full pipeline + portfolio context. Save articles for later. Resizable panel. Headlines cached with 6-hour TTL.

Pipeline DealPortfolio UpdateSector ResearchVC MarketGov't PolicyBig TechBreaking NewsEmerging Co.
Quantum computing startup raises $100M from Sequoia
3 hours ago

Permissions & Collaboration

Per-section granularity: control view/comment/edit access for each section of a deal, per user. Share deals with analysts while keeping financials partner-only.

Sarah Chen
Analyst
Details: EditAnalysis: ViewFinancials: None
Michael Rodriguez
Partner
All sections: Edit

Ready to prioritize the right deals?

Try VentureFlow